AKAP 12 Antibodies

Santa Cruz Biotechnology delivers a wide array of AKAP 12 monoclonal antibodies for research focused on A-kinase anchoring protein 12. AKAP 12 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 12 is crucial for the spatial organization of signaling pathways, particularly in the regulation of protein kinase A (PKA) activity. AKAP 12 plays a significant role in cellular processes such as cell adhesion, migration, and proliferation, making it an important target for studies related to cancer and cardiovascular diseases. Understanding AKAP 12 function can provide insights into the mechanisms of disease progression and potential therapeutic targets. Research has shown that AKAP 12 expression levels are altered in various pathological conditions, highlighting its importance in disease development. AKAP 12 has emerged as a key regulator of cell signaling networks, influencing multiple downstream pathways. Investigating AKAP 12's molecular interactions can reveal new therapeutic strategies for treating various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of AKAP 12's role in health and disease.